Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
    All Public Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • Eleven Minutes
    All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

WHAT'S NEW

  • Vaccine Policy in Colorado
  • Family Separation
  • Shakeup at U.S. Preventive Services Task Force
  • Ebola
  • ACA Enrollment

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Friday, Aug 5 2022

Full Issue

FDA Weighs 'Dose Sparing' To Increase Monkeypox Vaccine Capacity

The technique involves splitting a single vial of the Jynneos monkeypox vaccine into five smaller doses and would slightly change the way it is administered. FDA chief Robert Califf says, "It’s important to note that overall safety and efficacy profile will not be sacrificed with this approach.”

The Hill: FDA Considering Dividing Jynneos Doses Into Fifths To Increase Vaccine Supply

The Biden administration is considering splitting doses of the smallpox vaccine, which are being used to prevent monkeypox amid the current outbreak, into five smaller doses, the head of the Food and Drug Administration (FDA) said Thursday. (Choi, 8/4)

Updates on the spread of monkeypox —

The Washington Post: Monkeypox Spreads To D.C. Homeless 

Monkeypox has spread to D.C.’s homeless population, with two confirmed cases, as the city launches weekly walk-up vaccination clinics in an attempt to slow the spread of the virus. (Portnoy, 8/4)

Houston Chronicle: Houston To Test For Monkeypox Through Wastewater

Houston will begin monitoring its wastewater for monkeypox in late August as cases of the blister-causing contagion continue to climb, health officials said. Scientists will begin testing for the monkeypox virus in city sewage samples “starting in about three weeks,” Houston Health Department spokesperson Porfirio Villarreal said Thursday morning. (Mishanec, 8/4)

The Washington Post: As Monkeypox Strikes Gay Men, Officials Debate Warnings To Limit Partners

As the Centers for Disease Control and Prevention weighs whether to recommend limiting sex partners, health officials in San Francisco, Chicago, New York and other U.S. cities battling surges disproportionately sickening gay men are avoiding calls for sexual restraint, wary of further stigmatizing same-sex intimacy. (Nirappil and Jayakumar, 8/4)

Bloomberg: Most Of Africa’s Monkeypox Cases Are From Household Transmission: WHO

The rise of monkeypox cases in Africa, the only continent where the infectious disease is endemic, is coming from household transmission rather than primarily from men who have sex with men, according to the World Health Organization. (Kew, 8/4)

Also —

Atlanta Journal-Constitution: Marietta Woman Goes Public With Her Fight Against Monkeypox

A Marietta mother had never heard of monkeypox until she said she went to the hospital seeking answers to why she was feeling poorly. There, Camille Seaton learned that the painful, fluid-filled lesions on her face, which also eventually spread to her body was monkeypox. (Poole, 8/4)

The New York Times: A Stranger Filmed Her On The Train. TikTok Users Decided She Had Monkeypox. 

Lilly Simon, a 33-year-old in Brooklyn, does not have monkeypox. She does have neurofibromatosis type 1, a genetic condition that causes tumors to grow at her nerve endings. Those tumors were filmed surreptitiously by a TikTok user while Ms. Simon was riding the subway on a Thursday in late July during her commute. (Kircher, 8/4)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Friday, May 22
  • Thursday, May 21
  • Wednesday, May 20
  • Tuesday, May 19
  • Monday, May 18
  • Friday, May 15
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF